# ProAlgaZyme (Marine Algae Blend)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/proalgazyme
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-01
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** PAZ, Freshwater Algae Infusion, Fermented Green Algae Extract, Aqueous Fermented Algae Filtrate, Proprietary Algae Blend

## Overview

ProAlgaZyme is a proprietary fermented marine algae aqueous extract containing bioactive polysaccharides, phytosterols, and antioxidant pigments that modulate lipid [metabolism](/ingredients/condition/weight-management) and [oxidative stress](/ingredients/condition/antioxidant) pathways. Clinical data demonstrates it reduces total cholesterol by over 60 mg/dL and promotes statistically significant reductions in body fat in human subjects.

## Health Benefits

• Significant cholesterol reduction: Clinical trial showed mean total cholesterol reduction exceeding 60 mg/dL, with half of subjects achieving at least 36 mg/dL reduction in LDL-cholesterol (p < 0.001)
• Weight and body fat reduction: Statistically significant decreases demonstrated in human clinical trial over 10 weeks (p < 0.001)
• [Anti-inflammatory](/ingredients/condition/inflammation) effects: Significant reduction in C-reactive protein, interleukin-6, and red blood cell sedimentation rate observed in clinical study
• Blood sugar regulation: Fasting [blood glucose](/ingredients/condition/weight-management) levels significantly reduced in human trial participants (p < 0.001)
• HDL cholesterol improvement: Both human and animal studies showed significant increases in beneficial HDL-cholesterol levels

## Mechanism of Action

ProAlgaZyme's marine-derived phytosterols competitively inhibit cholesterol absorption in the small intestine by displacing cholesterol from mixed micelles, reducing hepatic LDL receptor downregulation and promoting LDL clearance from circulation. Bioactive sulfated polysaccharides from the algae blend exhibit antioxidant activity by scavenging [reactive oxygen species](/ingredients/condition/antioxidant) (ROS) and chelating pro-oxidant metal ions, reducing lipid peroxidation. Fermentation of the algae matrix is believed to enhance bioavailability of these compounds and may upregulate AMP-activated protein kinase (AMPK) pathways involved in fatty acid oxidation and metabolic regulation.

## Clinical Summary

A human clinical trial of ProAlgaZyme demonstrated a mean total cholesterol reduction exceeding 60 mg/dL, with statistical significance at p < 0.001, representing a clinically meaningful [cardiovascular risk](/ingredients/condition/heart-health) reduction. Fifty percent of trial subjects achieved a minimum LDL-cholesterol reduction of 36 mg/dL, and statistically significant decreases in weight and body fat were also recorded. The available published evidence is limited in scope — sample sizes, trial duration, and full methodology have not been broadly peer-reviewed in large independent studies, which constrains the strength of current conclusions. Independent replication in larger, randomized controlled trials is needed before ProAlgaZyme can be considered a first-line evidence-based intervention.

## Nutritional Profile

ProAlgaZyme is a fermented marine microalgae blend (aqueous fermentation extract) with bioactive compounds concentrated through proprietary fermentation processing. Specific macronutrient concentrations per serving are not publicly disclosed in detail, but the blend is characterized by: Bioactive compounds include algae-derived polysaccharides, phytosterols (notably beta-sitosterol and related sterols implicated in cholesterol-lowering mechanisms), and carotenoids (including astaxanthin, lutein, and beta-carotene typical of marine microalgae). Omega-3 fatty acids (EPA and DHA precursors) are present as constituent lipids of the microalgae cell membranes, though concentrations are low relative to dedicated fish oil supplements. Fermentation process is reported to enhance bioavailability of bioactive compounds by breaking down cell walls and pre-converting complex polysaccharides into more absorbable forms. Micronutrients include iodine, magnesium, potassium, and trace minerals naturally occurring in marine algae matrices. [Anti-inflammatory](/ingredients/condition/inflammation) bioactives are consistent with phycocyanins and chlorophyll derivatives. C-reactive protein reduction observed in clinical trial suggests meaningful systemic bioavailability of anti-inflammatory constituents. Protein content is minimal per typical serving dose. The product is delivered as a liquid aqueous extract, which may enhance absorption kinetics compared to dried algae powder formulations. Precise concentrations of individual bioactive compounds are proprietary and not published in peer-reviewed literature.

## Dosage & Preparation

The available research does not specify exact dosage information or standardized extract concentrations. The human clinical trial was conducted over a 10-week period using an oral liquid dietary supplement form, but specific daily doses were not disclosed in the sources. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

ProAlgaZyme is generally considered well-tolerated based on available clinical data, with no major adverse events prominently reported in existing trials, though comprehensive long-term safety profiling is lacking. Individuals taking statin medications or other lipid-lowering drugs should consult a physician before use, as additive cholesterol-lowering effects could theoretically increase the risk of hypocholesterolemia. Those with shellfish or algae allergies should exercise caution, as marine-derived ingredients carry a risk of cross-reactivity. Safety during pregnancy and lactation has not been established, and use is not recommended in these populations without direct medical supervision.

## Scientific Research

A peer-reviewed human clinical trial published in a National Institutes of Health journal demonstrated significant metabolic benefits over 10 weeks, including reductions in cholesterol, triglycerides, and [inflammatory](/ingredients/condition/inflammation) markers. Animal studies in hypercholesterolemic hamsters confirmed improved lipoprotein profiles and identified fifty plasma metabolites affected by PAZ treatment. Note: Specific PMIDs were not provided in the available research sources.

## Historical & Cultural Context

ProAlgaZyme is a modern formulation first marketed approximately 30 years ago (around 1996), rather than a traditionally used ingredient. No information about traditional use in historical medical systems was found in the available research.

## Synergistic Combinations

Red yeast rice, Plant sterols, Omega-3 fatty acids, Niacin, Berberine

## Frequently Asked Questions

### How much does ProAlgaZyme lower cholesterol?

In a published clinical trial, ProAlgaZyme produced a mean total cholesterol reduction of more than 60 mg/dL, which is a substantial drop comparable to moderate-dose statin therapy in some individuals. Half of the study participants achieved at least a 36 mg/dL reduction specifically in LDL-cholesterol, with results reaching statistical significance at p < 0.001. Individual results vary, and these findings require replication in larger independent trials before broad clinical recommendations can be made.

### What is ProAlgaZyme made from?

ProAlgaZyme is a proprietary aqueous extract derived from a fermented blend of marine algae species, processed to concentrate bioactive compounds including sulfated polysaccharides, phytosterols, and antioxidant carotenoid and chlorophyll pigments. The fermentation process is intended to break down the algae cell wall and enhance the bioavailability of these active constituents. The exact algae species composition and fermentation parameters are proprietary to the manufacturer.

### Does ProAlgaZyme help with weight loss?

Clinical data shows statistically significant reductions in body weight and body fat percentage in human subjects taking ProAlgaZyme, though specific figures such as mean weight lost or trial duration have not been fully detailed in publicly available summaries. The mechanism may involve AMPK pathway activation and improved fatty acid oxidation linked to the algae's bioactive polysaccharides. ProAlgaZyme should be considered a complement to diet and exercise, not a standalone weight-loss solution.

### Can I take ProAlgaZyme with statins or other cholesterol medications?

Combining ProAlgaZyme with statins such as atorvastatin or rosuvastatin, or with other lipid-lowering agents like ezetimibe, is theoretically possible but carries a risk of excessively lowering cholesterol levels below optimal ranges. Because ProAlgaZyme's phytosterols inhibit dietary cholesterol absorption through a complementary mechanism to statins, the combined effect may be additive. Always consult a licensed healthcare provider before combining ProAlgaZyme with any prescription lipid-lowering therapy.

### Is ProAlgaZyme safe for long-term use?

Long-term safety data for ProAlgaZyme is currently limited, as published clinical research does not yet include extended-duration trials examining effects beyond short-term supplementation periods. Short-term use appears well-tolerated based on available evidence, with no serious adverse events prominently reported. Individuals with algae allergies, autoimmune conditions, or those on prescription medications should seek medical advice before committing to long-term use.

### What does clinical research show about ProAlgaZyme's effectiveness?

Clinical trials demonstrate that ProAlgaZyme produces statistically significant results, with mean total cholesterol reduction exceeding 60 mg/dL and approximately half of subjects achieving at least 36 mg/dL reduction in LDL-cholesterol (p < 0.001). Additional research shows significant reductions in body weight and body fat over a 10-week period, as well as marked decreases in C-reactive protein, indicating meaningful anti-inflammatory effects. These outcomes support ProAlgaZyme's use for cardiovascular and metabolic health.

### Who would benefit most from taking ProAlgaZyme?

ProAlgaZyme is particularly beneficial for individuals with elevated cholesterol levels, those at risk for cardiovascular disease, and people seeking to improve body composition and reduce inflammation. The ingredient may be especially useful for those looking for a natural alternative or complement to conventional cholesterol management strategies. However, individuals currently taking cholesterol medications should consult their healthcare provider before supplementing.

### How does ProAlgaZyme's marine algae blend work in the body?

ProAlgaZyme's marine algae blend works through multiple mechanisms: it helps reduce circulating cholesterol levels, particularly LDL-cholesterol, while simultaneously supporting weight and body fat reduction and lowering inflammatory markers like C-reactive protein. The bioactive compounds in the marine algae work synergistically to address multiple aspects of metabolic and cardiovascular health. This multi-targeted approach makes it distinct from single-mechanism cholesterol supplements.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*